A previous report linked BMP signaling with RUNX3 (a tumor suppressor) in colorectal carcinoma, where the BMP-2 and BMP-4-mediated upregulation of RUNX3 expression inhibited tumor progression [26]. Here, RUNX3 is linked to neoplasm.